Schulman Bhattacharya


We are commercial litigators. Our focus is on resolving the most complex and challenging commercial disputes facing our clients—through litigation, arbitration, mediation, and informal negotiation. We have vast experience representing clients in nearly every industry sector. We represent companies of all sizes, locally, regionally, nationally, and internationally. We represent individuals with valuable commercial interests to protect. We represent both plaintiffs and defendants.

What sets us apart?
Results. Tenacity. Attention to Detail. Candor.

Recent News

U.S.-Based Internet Service Provider Blocks Malicious, Defamatory Articles Targeting Somali Union Leaders

Washington, D.C., January 16, 2018: Under pressure from Schulman Bhattacharya, A2 Hosting, Inc., the Michigan-based company hosting the website for Radio Dalsan in Mogadishu, Somalia, agreed to remove a series of demonstrably false and defamatory articles about the law firm’s client, Omar Faruk Osman. Mr. Osman is a leading member of civil society in Somalia and is an outspoken advocate for the rights of Somali journalists and other workers. Mr. Osman is the Secretary General of the National Union of... Read More »

Schulman Bhattacharya Forces $21.3 Million Buy-Out of Client’s Interests in Nine Washington Area Real Estate Companies

Schulman Bhattacharya secured a $21.3 million buy-out for its New Jersey-based client after a more than three-year effort to invoke and implement complex buy/sell provisions in the operating agreements for nine leading real estate companies in the Washington, D.C. area.  Jeremy Schulman was lead counsel in the engagement, assisted by Koushik Bhattacharya and Jeffrey Gavenman.  The Schulman Bhattacharya team crafted and prosecuted the strategy to secure a third-party buyer for various properties, present the offer to invoke the stipulated buy-sell... Read More »

Schulman Bhattacharya Client Wellstat Therapeutics Awarded Over $70 Million by Delaware Court

The Firm’s client, Wellstat Therapeutics, has been awarded an estimated $70 million against BTG International, Inc. in a pharmaceutical contract dispute in the Delaware Court of Chancery. Vice Chancellor J. Travis Laster issued a Memorandum Opinion, awarding Wellstat $55.8 million in damages plus prejudgment interest estimated to be in excess of $15 million plus attorney’s fees. In the lawsuit, Wellstat sued BTG over the marketing of Vistogard®, a life-saving drug designed to serve as an antidote for over-exposure to certain... Read More »

Schulman Bhattacharya Secures Confidential Settlement in Battle over Intellectual Property Royalties

Schulman Bhattacharya obtained a confidential settlement for our client after six days of trial before Judge Motz in the United States District Court for the District of Maryland. The case concerned a co-development agreement covering the creation and sale of valuable intellectual property rights for the training program “Negotiating with the Savvy Buyer.” We brought the suit for breach of contract, an accounting, and fraud, seeking unpaid royalties and punitive damages for sales of the program over a more than... Read More »

Schulman Bhattacharya Secures $19.5 Million Settlement in Hotly-Contested Real Estate Dispute

Schulman Bhattacharya won a $19.5 million settlement for clients in a dispute over the application of a complex buy/sell provision in a real estate company’s operating agreement. The case settled on the fifth day of trial, after our successful cross examination of the opposing side’s key witnesses and as we were nearing completion of putting on our case in chief. The Schulman Bhattacharya team was headed by partners Jeremy Schulman and Koushik Bhattacharya. Mr. Schulman was lead counsel in the... Read More »

Relentless pursuit of successful results for our clients.

We have recovered hundreds of millions of dollars for our clients and we have successfully defended clients facing billions of dollars in potential liabilities.

Proudly serving clients from our headquarters in metropolitan Washington, D.C. and from our branch office in Maryland’s dynamic bio-technology corridor.

Jeremy W. Schulman

Koushik Bhattacharya

Jeffrey S. Gavenman

Edwin R. Schulman

An experienced team with a proven track record of success.